Sarcena, Judith L.

HRN: 07-60-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2022
CEFTRIAXONE 1G (VIAL)
06/21/2022
06/27/2022
IVTT
2g
Q24
Urinary Leukocytes And Pus Cells
Waiting Final Action 
06/25/2022
CIPROFLOXACIN 500MG (TAB)
06/25/2022
07/01/2022
ORAL
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: